BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12891602)

  • 1. Clinical outcomes following stent implantation in internal mammary artery grafts.
    Sharma AK; McGlynn S; Apple S; Pinnow E; Canos DA; Gevorkian N; Tebeica M; Gruberg L; Pichard AD; Lindsay J
    Catheter Cardiovasc Interv; 2003 Aug; 59(4):436-41. PubMed ID: 12891602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting stents for the percutaneous treatment of the anastomosis of the left internal mammary graft to left anterior descending artery.
    Zavalloni D; Rossi ML; Scatturin M; Morenghi E; Soregaroli D; Municino A; Gasparini GL; Lisignoli V; Barbaro C; Presbitero P
    Coron Artery Dis; 2007 Sep; 18(6):495-500. PubMed ID: 17700223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
    Pucelikova T; Mehran R; Kirtane AJ; Kim YH; Fahy M; Weisz G; Lansky AJ; Moussa I; Gray WA; Collins MB; Kodali SK; Stone GW; Moses JW; Leon MB; Dangas G
    Am J Cardiol; 2008 Jan; 101(1):63-8. PubMed ID: 18157967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
    Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion.
    Brodie BR; VerSteeg DS; Brodie MM; Hansen C; Richter SJ; Stuckey TD; Gupta N; Pulsipher M; Downey W
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):504-9. PubMed ID: 15988742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of outcomes between bare metal stents and drug-eluting stents for percutaneous revascularization of internal mammary grafts.
    Buch AN; Xue Z; Gevorkian N; Torguson R; Fournadjieva J; Deible R; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2006 Sep; 98(6):722-4. PubMed ID: 16950170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention of or through saphenous vein grafts or internal mammary arteries: the impact of stents, adjunctive pharmacology, and multicomponent distal protection.
    Morrison DA; Thai H; Goldman S; Felix E; Hernandez J
    Catheter Cardiovasc Interv; 2006 Apr; 67(4):571-9. PubMed ID: 16547927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated coronary revascularization: percutaneous coronary intervention plus robotic totally endoscopic coronary artery bypass.
    Katz MR; Van Praet F; de Canniere D; Murphy D; Siwek L; Seshadri-Kreaden U; Friedrich G; Bonatti J
    Circulation; 2006 Jul; 114(1 Suppl):I473-6. PubMed ID: 16820621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transluminal angioplasty to left internal mammary artery grafts: immediate and long-term clinical outcomes.
    Hung WC; Wu CJ; Yip HK; Fang CY; Hang CL; Chen SM; Chen MC; Yu TH; Wang CP; Hsieh YK
    Chang Gung Med J; 2007; 30(3):235-41. PubMed ID: 17760274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and intermediate-term procedural results using cypher stenting to treat multi-vessel coronary artery disease.
    Kornowski R; Vaknin-Assa H; Assali A; Fuchs S
    Int J Cardiovasc Intervent; 2005; 7(3):122-5. PubMed ID: 16243732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
    Meliga E; García-García HM; Kukreja N; Daemen J; Tanimoto S; Ramcharitar S; van Mieghem CA; Sianos G; van der Ent M; van der Giessen WJ; de Feyter P; van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):21-5. PubMed ID: 17584913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term outcomes of the titanium-NO stent registry.
    Mosseri M; Tamari I; Plich M; Hasin Y; Brizines M; Frimerman A; Miller H; Jafari J; Guetta V; Solomon M; Lotan C
    Cardiovasc Revasc Med; 2005; 6(1):2-6. PubMed ID: 16263349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002.
    Hoye A; van Domburg RT; Sonnenschein K; Serruys PW
    Eur Heart J; 2005 Dec; 26(24):2630-6. PubMed ID: 16183693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long drug-eluting stent implantation for a diffusely diseased right internal mammary artery.
    Niccoli G; Biscione C; Conte M; Crea F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):381-3. PubMed ID: 17443108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 10-year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial.
    Goy JJ; Kaufmann U; Hurni M; Cook S; Versaci F; Ruchat P; Bertel O; Pieper M; Meier B; Chiarello L; Eeckhout E;
    J Am Coll Cardiol; 2008 Sep; 52(10):815-7. PubMed ID: 18755343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft.
    Mehta RH; Honeycutt E; Peterson ED; Granger CB; Halabi AR; Shaw LK; Smith PK; Califf RM; Harrington RA; Sketch MH
    Circulation; 2006 Jul; 114(1 Suppl):I396-401. PubMed ID: 16820607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
    Han YL; Wang SL; Jin QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
    Chin Med J (Engl); 2006 Apr; 119(7):544-50. PubMed ID: 16620694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
    Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
    Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.